The Effect of Far Infrared Treatment on Changes in Biomarkers in the Arteriovenous Fistula
Blood Purification · 2025
DOI: 10.1159/000547478 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Blood Purification, 2025. Verfasst von Emilie K Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Herlev Hospital, Herlev, Denmark, emilie.klara.hansen.03@regionh.dk. Hauptthemen laut MEDLINE: Renal Dialysis, Infrared Rays, Arteriovenous Shunt, Surgical. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
Far infrared radiation may improve arteriovenous fistula maturation and patency rates in patients on hemodialysis (HD). The mechanism is proposed to involve anti-inflammatory and vasodilatory effects in the arteriovenous fistula. This study examined the impact of far infrared radiation on plasma changes and dialysate excretion of biomarkers of endothelial dysfunction, inflammation, and vasodilation in the arteriovenous fistula during a single HD.
Methods
The study was a randomized, controlled, single-blinded study involving 44 participants on HD with an arteriovenous fistula. Participants were randomized to far infrared radiation or no far infrared radiation (control). Blood samples and dialysate water were drawn before, during, and after 4 h of HD. The change and elimination of biomarkers of endothelial dysfunction, inflammation, and vasodilation was explored in blood and dialysate water, respectively. Changes in plasma levels from the start to the end of HD and the area under the curve for the biomarker concentration were compared between groups by ANCOVA.
Results
There was no difference in the change of biomarkers of endothelial dysfunction, inflammation, and vasodilation between the two groups after and during 4 h of HD. There was a minimal excretion of the biomarkers in the dialysate water. Regardless of the treatment group, 4 h of HD caused a significant decrease in tumor necrosis factor-alpha (−1.30 [−1.70; −1.03] pg/mL, p < 0.001), monocyte chemoattractant protein-1 (−32.50 [−50.50; −8.25] pg/mL, p < 0.001), nitrite and nitrate (−20.00 [−27.75; −14.00] µmol/L, p < 0.001) as well as asymmetric dimethylarginine (−0.24 [−0.28; −0.18] µmol/L, p < 0.001).
Conclusion
Overall, the study is not supportive of a beneficial effect of far infrared radiation on the arteriovenous fistula on biomarkers of endothelial dysfunction, inflammation, or vasodilation during one HD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Herlev Hospital, Herlev, Denmark, emilie.klara.hansen.03@regionh.dk.
- Department of Nephrology, Herlev Hospital, Herlev, Denmark.
- Institute of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
- Department of Internal Medicine (Cardiovascular Disease), Maastricht University Medical Centre, Maastricht, The Netherlands.
Zitieren
APA
Hansen, E. K., Hansen, D., Schalkwijk, C., Waarenburg, M., Hansen, H. P., & Lindhard, K. (2025). The Effect of Far Infrared Treatment on Changes in Biomarkers in the Arteriovenous Fistula. Blood Purification. https://doi.org/10.1159/000547478
Vancouver
Hansen EK, Hansen D, Schalkwijk C, Waarenburg M, Hansen HP, Lindhard K. The Effect of Far Infrared Treatment on Changes in Biomarkers in the Arteriovenous Fistula. Blood Purification. 2025. doi:10.1159/000547478
BibTeX
@article{Hansen2025,
author = {Hansen, Emilie K and Hansen, Ditte and Schalkwijk, Casper and Waarenburg, Marjo and Hansen, Henrik Post and Lindhard, Kristine},
title = {The Effect of Far Infrared Treatment on Changes in Biomarkers in the Arteriovenous Fistula},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000547478}
}
EUVIMED